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In  the  present  report  an in  vitro method  for  obtaining  a 
secondary  human  antibody  response  to  a  dog  kidney  cell 
vaccine  against  rabies  virus  (DKCV)  is  described.  Cultures 
of peripheral  blood  mononuclear  cells  from  normal  rabies- 
immune  and  nonimmune  donors  were  stimulated in  vitro 
by DKCV. The production of virus-specific antibody in 
supernatant  fluids  was  monitored  by  ELISA.  Antibody  was 
produced by lymphocytes from rabies-immune individu- 
als, whereas those of nonimmune subjects consistently 
failed to  produce  anti-rabies  antibodies  after in vitro stim- 
ulation  with  DKCV.  The  generation  of  the  anti-rabies  virus 
antibody  response  of  lymphocytes  stimulated  with DKCV 
was shown to be an antigen-dependenty as well as an 
antigen-specific  process.  Optimal  antigen-specific  re- 
sponses were observed at  relatively low  concentrations 
of  antigen (10” to lo’* pg/culture).  At  increasing  concen- 
trations of antigen in culture (>1 pg/culture), the anti- 
rabies virus response was suppressed. Antibody pro- 
duced  upon  stimulation  was  capable  of  neutralizing  rabies 
virus. The response to rabies virus requires T cell help 
because  lymphocytes  depleted  of SE rosetting  cells  did 
not  respond  to  an  antigenic  stimulus.  Studies  in  which  the 
same  individuals  were  followed  over  time  showed  a  se- 
quential development of circulating B cell subsets. The 
system may provide a model for the study of human B 
cell  differentiation in  vivo and in  vitro and  may be valuable 
for  testing  the  potency  of  rabies  vaccines in vitro. 
Polyclonal  B  cell activators (PBA)’  have  been  a  useful  probe 
to study  activation  and  regulation  of B lymphocyte  responses  in 
man.  Antigen-specific  antibody  responses,  however, that  result 
from exposure of human B cells in vitro to PBA, such as 
pokeweed  mitogen,  are  part  of  a  polyclonal  immunoglobulin  (lg) 
response.  The latter  type of response  may  greatly differ  from B 
cell  responses  triggered  by  antigen  itself (1 -3). 
Several investigators have recently established techniques 
that  permit  analysis  of  either  the  primary  or  secondary in  vitro 
antibody  response  by  human 6 cells after  antigen  stimulation. 
Antigens  applied in these  studies  included  particulated  antigens, 
i.e.,  sheep red  cells (SE) (4-7), haptenated  polyacrylamide  beads 
(B), and  soluble  antigens,  such  as  ovalbumin (4, 5), haptenated 
ovalbumin (9), keyhole limpet hemocyanin (KLH) (10, l l ) ,  he- 
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hemocyanin; HEPES. N-2-hydroxyethylpiperazineN’“hthanesulfonic acid;  ELISA, 
mocyanin of helix pomatia (1 2), and tetanus toxoid (1 3-15). 
Furthermore,  systems  have  been  described that have  enabled 
the measurement of specific antibody in cultures of human B 
cells stimulated  with  influenza  virus (16, 17) and  varicella  zoster 
virus (1 8). 
In  this paper,  we report  the in  vitro induction  of  a  secondary 
antigen-specific antibody response of human peripheral blood 
lymphocytes  (PBL)  by  a  dog  kidney cell vaccine  against  rabies 
virus (DKCV). This  vaccine  has  proven to be a  potent  inducer  of 
neutralizing  antibody  in  man (19). In addition, it has  been  shown 
to protect animals  against  an  otherwise  lethal  challenge with live 
rabies  virus (19). The  kinetics of this response, “the  quality”  of 
antibody  produced,  as  well  as  the  cellular  requirement  for this 
response,  have  been  investigated. 
MATERIALS AND METHODS 
immunization of one dose of DKCV followed by a 1- and 6-mo booster 
Immunizations. Normal  healthy  volunteers  received a  primary intramuscular 
irnmunizatlon Of by  immunization  on  days  7  and 21 as  indicated in Resuks. 
Before  immunization,  anti-rabies  antibodies  were not present  in  the  sera  of 
the  subjects  as  has  been  reported  (19).  After  completion  of  the  vaccination 
schedule,  neutralizing  anti-rabies  antibodies  were  present  in  sera  of  all  indi- 
indicated in Results. 
viduals. In vitro studies were performed at times after immunization as 
Lymphocyte isolation. Mononuclear cells were isolated from heparinized 
Mood by  density  gradient  centrifugation  on  Ficoll-lsopaque (p = 1.077  g/cm3) 
at 1000 X G  for 20 min  and  then  were  washed  twice  with RPMl1640 (GIBCO, 
Grand  Island, NY) supplemented  with  penicillin,  streptomycin,  and  Fungizone 
(100 IU, 100 pg, and 25  pg/ml,  respectively). 
adherence to plastic  Falcon  flasks  at 37’ C in RPMl  1640  medium supple 
Monocyte depletion. Mononuclear cells  were  depleted  of  monocytes  by 
mented  with 20% fetal calf serum  (FCS).  After 60 min,  Supernatants  containing 
lymphocytes  were  harvested  and  washed  twice in RPMl1640 medium. After 
the  adherence  procedure.  the cell suspension  usually  contained  between  5 
and 10% monocytes determined by morphology and nonspecific esterase 
staining. 
T cell isolation and depletion.  Mononuclear  cells  were  separated  into T cell 
and  non-T  cell  populations  by  methods  previously  described  (5).  Briefly, T 
cells were  isolated  by  incubation of lymphocytes  with  a  50-fold  number  of  SE 
that  had  been  treated  with  neuraminidase.  After  rosette  formation, cells were 
centrifuged on a  density  gradient  of  Ficoll-lsopaque (p = 1.077 g/cm3) for 30 
min  at  1200 x G.  The  resulting T cell  sediment  was  freed of contaminating 
SE by lysis with cold buffered NH4CI. The cells from the interface of the 
gradient  that  were  enriched  for  B  cells  were  cycled  again.  Non-T cell prepa- 
rations  used in the  experiments  contained 52% SE rosetting cells. 
propagation  of  rabies  virus  strain  Wistar  PM/WI 38-1 5033M in primary dog 
Antigens.  Rabies  vaccine  used  for  stimulation i vitro  was  produced  by  the 
kidney cells (DKCV)  and  was  inactivated with p-propiolactone  as  described 
was  dissolved in 1 ml  phosphatebuffered  saline  (PBS)  and  was  further  dlluted 
elsewhere (20). One dose of lyophilized vaccine containing 300 r g  protein 
obtained from MBrieux  (France).  Measles  virus  (Edmonston  strain)  was  grown 
in culture medium. Rabies vaccine produced in human diploid cells was 
on  Vero cells in microcarrier  cultures  and  was  purified  according to methods 
used  for  the  purification of rabies  virus (20). Polio  virus  was  produced  and 
purified  according to methods  described  by  van  Wezel  et  a/. (20). 
containing 25 mM HEPES,‘ 2 mM L-glutamine, penicillin, streptomycin, and 
Culture  conditions.  Lymphocytes  were  suspended in RPMl 1640 medium 
Fungizone, 100 IU, 100  pg/ml,  and  25  pg/ml,  respectively, lo” M 2-mercap 
toethanol,  1  mM  Na  pyruvate,  and  10%  horse  serum.  Cells  were  cultured in 
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the  presance  of  various  concentrations  of  DKCV.  Cultures  were  kept  in  24- 
well,  flat-bottomed  plates (Costar Data  Packaging,  Cambndge.  MA)  at  a cell 
density of 2 x 1@/ml in a final volume of 1 ml at 37" C in a humidfied 
atmosphere  of 5% Con in air. After 6 days the cells were  harvested,  washed 
twice, and recultured  for 5 days in culture  medium  containing 5% FCS  (Amxxrr 
Pharmaceutical  Company,  Kankakee, IL) without antigen. Supernatant  fluids 
were then harvested and assayed for a n t i "  antibody, for  antibody  to 
@io  virus, and for total  lg. 
Enzyme-linked immunoswbmt assays (€USA). Antibodies to rabies  virus 
in  culture  supernatants  were  detected  by soridphase immunoassay  with the 
use of a m o d i t i o n  of the method of Zanders et a/. (21).  Flat-bottomed 
microtiter  plates  (Titertek  Type 111, Flow  Laboratories IN.,  Mclean, VA) were 
coated  with  100 pl of  12  pgglml  DKCV  in  PBS,  pH  7.4,  for  1  hr  at  37'  C in  a 
humidified  atmosphere.  Plates  were  washed twice with  PBS.  incubated  with 
PBS  containing 1% bovine serum albumin  (BSA) for 30 min  at  37"  C to block 
This  procedure  consistently  resulted in low background values.  After washing, 
remaining binding sites, and washed again with PBS containing 1% BSA. 
60 of culture supernatant and dilutions thereof in PBS 0.5% BSA were 
applied to the wells and were  incubated for 1  hr  at  37"  C. Miluted culture 
supernatant, as well as three serial fivefold dilutions, were run for each 
sample.  Each  plate  also  contained  four  serial  fivefold  dilutions  of  a  reference 
serum composed of poded serum of a  hyperimmune donor. The plates were 
washed with PBS containing 0.05% Tween by using a semi-autom@c 
washing device and were incubated at room temperature for 2 hr with 
antihuman Ig conjugated with peroxidase;  goat anti-p chain  (Cappel  Labora- 
tories, Downingtorm, PA), sheep anti-human y-chain, and polyspedfic sheep 
anti-human lg were used. The production of the latter two conjugates  has 
been described elsewhere (22). The conjugates  were  diluted  in  PBS  contain- 
ing 0.5% BSA. After incubation with conjugated antisera the plates were 
washed  with  PBS  containing 0.05% Tween, and 100 pl of the substrate  were 
added to each well. The substrate  consisted of 1.67 ml tetrarnethyl-benzidine 
in dimethylsulfoxide (6 mg/ml) in 100  mlO.1 M sodium  acetate  buffer, pH 5.5. 
and 10 of 30% solution of H h  (Pehydrole, Merck. Darmstadt). After 10 
min, the reaction  was  stopped  by the a d d i i  of 100 &well 1 N HzS04 (23). 
Abmrbewe at  450  nm  was  measured  by  using  a  Tiiertek Multiskan automatic 
calculate the concsntration  of  IgM and IgG  in  supernatant  fluids,  the optical 
plate reading machine connected with a PDP 1170 computer system. To 
densitii of samples and reference  serum  were  compared. For this  purpose 
we  developed  a  line comparison method.  To  find out w h i i  combination  of 
(van Asten et a/ . ,  unpublished data). Configurations that had been pre 
configurations would  give the best c o n e l a t i o n ,  a  computer  program  was u ed 
grammed  were: linear, bgarithm, redprocal,  probit  square, and square  root. 
On the basis of  data  obtained with 72 samples, the combination of bgarithm 
of  concentration vs linear extinction  was selected. Next, the actual concen- 
tration  in  nanograms of lg in  a sample was  calculated by the determination 
of  the slope ratio of the slopes of the best-fitting  line of both the reference 
and sample. By  using  this  method,  slight differences in  background  values 
did not  influence the final results. Large differences 
however,  were noticeaMe by poor correlations that  automatically  indicated 
in background values, 
the  necessity to repeat the test. 
Standardization of the reference serum. The reference serum was stan- 
dardized according to the method described by Stevens and Saxon (24), 
The amount of rabies-specmc lg in the reference was estimated by the 
which provides an estimate  of the antibody content  in  nanograms per milliliter. 
comparison of the amount  of lg reference serum bound to microtiter  wells 
coated with DKCV with the amount of an lg standard  bound to microtiter 
wells  coated  with  anti-lg antibody. The plates  were  coated  with  150  pl/well, 
5 pg/ml pdyspecific sheep anti-human lg antibody, or 12 pg/ml DKCV in 
carbonate buffer, pH  9.6,  by  incubation  at  20°  C  for  24  hr. After washing, 
wells  coated  with  anti-Ig  antibody  were  filled  with  100 @I of  dilutions  of an lg 
standard preparation, whereas wells coated with virus received 100 of 
serial  fivefold  dilutions  of the reference serum. After  2  hr  at  37"  C,  the  plates 
were washed, and 100 pl of purified peroxidaseconjugated pdyspecmC 
sheep anti-human lg (22) were applied to each well. After 2 hr at 37" C, 
plates  were  devebped as described above. The amount  of  rabies-specific lg 
in the reference  was  estimated  by comparison of the optical densities  obtained 
determination of rabies-spedfic IgM  and  IgG in the reference  was estimated 
with  virus-coated wells with the curve  obtained with anti-lgcoated wells. The 
in  an identi  manner.  Goat anti-human p-chain-specific  (Cappel  Laboratories) 
and sheep antihuman y-chain-speafic (22) antisera were used to coat 
microtiter  wells.  Purified  human  lgG and IgM  were used as standard prepa- 
r a t i s .  To develop the plates,  a  polyspecifk  sheep anti-human lg conjugated 
with  peroxidase  was used (22). 
Virus-neutra/izinQ  antibody  determination. The neutralizing capacity of 
fluorescent  focus  inhibition  test (RFFIT) (25). 
culture  supernatants on rabies  virus  (CVS  strain)  was  evaluated  by  the  rapid 
RESULTS 
Antigenic  requirements.  Anti-rabies  antibody  responses  were 
seen  at  concentrations  of  DKCV in lymphocyte  cultures  as  low 
as 10" pg protein/culture. Peak responses were observed at 
concentrations  ranging  from to 10" pglculture of  DKCV. 
The  further  increase  of  antigen  concentration  in  culture (>1 pg/ 
culture)  resulted  in  the  abrogation  of  antibody  formation  (Fig. 1). 
This has been a consistent finding with cells from 25 rabies- 
vaccinated individuals who were studied. Lymphocytes from 
nonimmunized  subjects  failed to respond  to  rabies  vaccine  at  all 
concentrations  that  were  tested. 
To determine whether the antibody generated by DKCV in 
vitro  resulted  from  de  novo  protein  synthesis,  antigen-stimulated 
cells were  cultured  in  the  presence  of 100 pg/culture  cyclohexi- 
mide.  The  addition  of  cycloheximide 5 days  before  the  harvesting 
of  culture  supernatants  reduced  antibody  production  to  less  than 
10% of  values  found  in  supernatants  of cells cultured  without 
this drug  (Fig. 1). Furthermore,  no  antibody  production  could be 
detected  in  cultures  of  cells  with  medium  alone (0 pg/culture of 
DKCV)  (Fig. 1). 
Kinetics of the in vitro anti-rabies response. Time course 
studies  were  performed to define  the in vitro  kinetics of the  anti- 
rabies  antibody  production.  Cells  were  cultured  for  various pe- 
riods  after  which  the  supematants  were  tested  for  the  presence 
of  specific  antibody  in  the  ELISA.  Specific  antibody  production 
was not detected through day 3 of culture. Then antibody 
production  increased to a maximum  by  day  10  or 11 (Fig. 2). To 
avoid  residual  antigen  present  in  the  culture  supernatant  affecting 
the detection of specific antibody, the following experiments 
were performed. After an incubation period of 4 days in the 
presence  of  antigen,  cells  were  washed free of  antigen  and  were 
cultured  again  in  fresh  media  for  an  additional  period  of 6 to 7 
days. The supernatants were then assessed for antibodies 
against  rabies  virus.  The  results  of  these  experiments  showed 
again  that  maximal  and  constant  production  of  specific  antibody 
was detected after a period of culture of 10 days (data not 
shown).  These  results  argue  against  an  assay  artifact  related  to 
antigen  in  culture  and  confirm  the  data  obtained  with  cyclohexi- 
mide  studies  that  indicate  that in vitro  protein  synthesis  is r e  
quired  for  this  response. 
Antigen-specific  nature  of  the  response  to  rabies  vaccine.  The 
I 
o 10-4 10-3 10-2 10-1 1 10 30 
DKCV concentration (,ug/culture) 
in the presence of different concentrations of DKCV. Specific antibodies in the 
Figure 1. Antigen dose depandency of anti-rabies response. PBL were cultured 
culture supernatant fluid were  determined on day 11. Three  representative experi- 
ments from different donors are shown. Values are expressed  as mean ng $/ml f 
SE of triplicate  determinations. 
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Figure 2. The  kinetics  of  anti-rabies  antibody  formation  in  cultures  of  PBL.  Cells 
were  cultured  for  various  periods in the  presence  of  0.1 pglcutture DKCV. One 
representative  experiment is shown.  Values  are  expressed  as  mean  ng I /ml f SE 
of  triplicate  determinations. 
TABLE I 
Smificitv of anti-rabies resmnse 
Supematant Specific Antibod9 
Culture 
sorbed Stimulus 
ELSA wat  Fluid  Ad- 
witH Polio  virus DKCV  DKCE' 
None 
DKCV 
0.1  11 f 0.017  0.094 f 0.023 
1.699 f 0.013 0.070 f 0.021 
Polio  virusd 1.494 f 0.013 0.065 f 0.026 
OKCV 0.131 f 0.049 1.477 f 0.154 
DKCV DKCV 
DKCV 
0.330 2 0.012 
DKCV 
Measles  virus 1.620 f 0.022 
Polio  virus 1.660 f 0.034 
DKCV, 300 pg/ml;  measles  virus, 150 pg/ml;  polio  virus, 33 pg/ml.  for  1  hr  at  37°C. 
"supernatant fluids were adsorbed with 1 vol highly concentrated antigen: 
After  centrifugation  supernatant  fluids  were  tested  for  specific  antibody. 
out of three is shown. 
a Data  expressed  as  mean OD 450  nm f SE.  One  representative  experiment 
cells were  washed  free  of  serum  and  were  subjected to three  cycles  of  freezing 
Dog  kidney  cells  were  cultured  as  described in Reference  20.  The  noninfected 
and thawing. The clarified supernatant fluid was diluted with PBS, pH 7.4, to a 
coat  in  ELISA  DKCE. dog kidney  cell  extract. 
protein  content  of 12 pg/ml.  One  hundred  microliters  of  this  material  was  used  as 
The  antibody  response  induced  by  polio  virus in vitro  will be described  in  detail 
elsewhere (UytdeHaag et a/., manuscript in preparation). Background values in 
absorbence. 
ELISA for determination of anti-pdii virus antibody were usually below 0.100 
specificity of the response was assessed by culturing cells of 
individuals  who  were  double  immune to rabies  virus  and to polio 
virus with DKCV or polio  virus  and  by  testing  supernatant  fluids 
for  antibodies  against  rabies  virus  and  polio  virus.  The  outcome 
of  such  experiments  revealed  evidence that  antibody  generated 
by  DKCV in vitro was  specific  for  the  inducing  antigen,  because 
no significant  production of antibodies  against  polio  virus  was 
observed (Table I). On the other hand, supernatant fluids of 
cultures  stimulated with polio  virus did not bind to DKCV  used 
in the  ELISA. In the latter cases,  specific  antibodies to polio  virus 
could be detected by  using  the  homologous  antigen in the  ELISA. 
The  specificity of the  response  could be further  established  by 
the  absorption of the  culture  supernatant  fluids with the  immu- 
nizing antigen or an unrelated antigen. The addition of excess 
rabies  vaccine to culture  supernatant  fluids  of  the  rabies  vaccine- 
stimulated  cells  before  determination of the  antibody  content  in 
the  ELISA resulted  in  a  diminished  antibody  response.  Absorp- 
tion with measles  virus or polio  virus  did not sighificantly  change 
the level of antibodies in supernatant fluids of rabies vaccine- 
stimulated  cultures  (Table I). 
Although DKCV used to stimulate the cultures is relatively 
pure and  antibodies to dog  kidney cells have  never  been  found 
in individuals  immunized  with  DKCV  (unpublished  observation), 
the  generation of antibody  against dog kidney cel antigens  was 
considered after stimulation of lymphocytes with DKCV. The 
supernatant  fluids  from  cultures  of  different  individuals  containing 
rabies-specific  antibody  were  tested  in  ELISA  against  a  coat  of 
noninfected dog kidney  cell  extracts.  None  of  these  supernatant 
fluids  showed  a  significant  reaction i ELSA (Table I). 
The nonpolyclonal nature of DKCV. The possibility that an 
antigen may behave like a polyclonal activator cannot be ex- 
cluded (26). This possibility was tested by culturing PBL with 
various  concentrations of DKCV or in the absence of antigen. 
As can be seen in Figure 3, the  characteristic  bell-shaped  dose- 
response  curve  was  obtained  for  rabies-specific  antibody  when 
PBL  were  exposed to various  concentrations  of  DKCV.  Total g 
production,  however,  did  not  vary  significantly  among  stimulated 
and  non-stimulated  cultures  indicating  that,  at  least  in  this  sys- 
tem,  DKCV  does not  provide  a  polyclonal  stimulatory  signal to 
PBL. 
In vivo kinetics of rabies-specific  antibody  production.  In  PBL 
cultures  from  six  individuals  who  were  followed  over  time, an in 
vitro antigen-inducible antigen-specific IgM antibody response 
was observed 1 wk after primary immunization. When taken 
before immunization with DKCV,  PBL  of  these subjects  did  not 
respond to antigenic  stimulation in vitro  (Fig. 4). Maximal in vitro 
antigen-induced, rabies-specific IgM responses were observed 
in PBL cultures of all  individuals 2 to 5 wk after  the first booster 
immunization (Fig. 4). When examined 1 wk after the primary 
immunization, PBL of some subjects produced rabies-specific 
IgM  antibody  when  cultured in the  presence of very  low, other- 
wise nonstimulatory concentrations of antigen; moreover, this 
0 1o-L l f i  10-2 10-1 1 10 100 
DKCV concentration ( ~ ~ g l c u l t u r e )  
uals  induced  by  DKCV in vitro.  Data  are  expressed as geometric  means f SE. 0. 
Figure 3. The  nonpolyclonal  nature  of  antibody  responses of PBL  of  five  individ- 
specific  anti-rabies  virus  IgG; 0. total IgG. 
IN VlTRO RABIES-SPECIFIC  ANTIBODY  PRODUCTION 1237 
I 
i 
\ 
\ 
111 
3 c s-" .d""&" 
0 7 21 42 90 280 
days after immunization 
Figure4. The in vivo kinetics of in vitro anti-rabies virus response of eght 
0, rabies  virus-specific  DKCV-induced  IgM  antibody.  Lower  panel; 0, rabiis virus- 
individuals. Upper panel; 0, rabies  virus-specific  non-antigen-induced IgM antibody; 
specific  non-antigen-induced  IgG  antibody; 0, rabies  virus-spectfic  DKCV-induced 
IgG antibody.  Data  are  expressed as mean  responses of eight  individuals  in  ng  lg/ 
ml f SE. 
response  was  also  seen i   the  absence  of  antigen.  This  phenom- 
enon  of  nonantigen-induced  rabies  virus-specific IgM production 
was  markedly  expressed in cultures of PBL of most individuals 
when tested 3 wk after primary immunization, i.e., 2 wk after 
repeat  immunization,  and itwas  no  longer  detectable 13 wk  after 
primary  immunization  (Fig. 4). When tested 40 wk  after  primary 
immunization, PBL of most individuals showed a decreased 
antigen-inducible  specific IgM response,  whereas PBL of other 
individuals became unresponsive. This phenomenon occurred 
irrespective of persistent levels of circulating neutralizing anti- 
bodies.  Cells  from  other  subjects,  however,  could be stimulated 
by  DKCV to produce  specific  IGM  antibody in vitro up to 40 wk 
after  the  primary  injection  (data  not  shown). 
Low  levels  of  rabies  virus-specific  IgG  antibody  were  found  in 
cultures of PBL of some  subjects  as  early  as 1 wk  after  primary 
immunization.  The  cells of all but one  individual  could be triggered 
by  antigen to produce  rabies  virus-specific  IgG  antibody  between 
2 and 40 wk after the first booster immunization (Fig. 4). The 
magnitude  of  those  responses  was  highly  variable. PBL of  one 
subject  could  not be stimulated  by  rabies  virus to produce  IgG 
antibody  despite  the  ability  of  those  cells to secrete  specific  IgM 
spontaneously, as well as in response to antigen (data not 
shown). 
Neutralizing antibody activity in culture supernatant fluids. 
Culture  supernatant  fluids  containing  antigen-binding  rabies vi- 
rus-specific  antibodies  shown  by ELISA were  examined  for  the 
presence of neutralizing antibodies to rabies virus. In most 
supernatant fluids that were tested, neutralizing antibodies to 
rabies  virus  could be demonstrated.  Some culture  supernatants, 
TABLE II 
Rabies  virus-neutralizing  antibodies  produced in Vitro 
~xper i -  Days after Antiqabies lg Culture Supematant Anti-rabies 
ment Bmstef Fluids Serum 
1 18 173 f 14" 1 .r 11.4" 
2 18 174 -e 31 1 .o 14.3 
3 18 93 f 17  <0.1  3.5 
4 18 161 f 8 0.3 14.0 
5 250 
6  1 46 
127 f 29 0.2 5.0 
106-e9 co.1 7.0 
zaticm at the times indicated. After stimulation of the cells with DKCV, culture 
a Peripheral Mood was  obtained from six  different  donors  after  booster  immuni- 
supernatant fluas were  tested for antigen  binding  in the ELSA and  for  the  presence 
of neutralizing  antibodies  as described in Maierias and Methods. 
Values  are  expressed as ng  lg/ml f SE of duplicate  determinations  in  ELISA. 
International  units ( I V )  determined  in RFFIT. Essentially  the  same  results  were 
obtained  in  a mwse protection  test. 
PBL 
were  separated  in  T and  non-T  cells. 1 x 10' non-T  cells  were  cultured with  various 
Figure5 T cell dependency of anti-rabies antibody production. Human PBL 
numbers  of  T  cells  and  in the presence  of 0.1 pg  DKCV/culture.  Two  representative 
experiments with two different donors are  shown.  Antibody  responses of separated 
reconstituted cells and  unseparated PEL are  expressed  as  mean  ng  lg/ml k SE of 
triplite determinations. 
however, lacked detectable amounts of neutralizing antibody 
activity.  In  the  sera  of  all  subjects,  neutralizing  antibodies  were 
found  (Table 11). 
Cellular requirement. To investigate whether there was a T 
cell dependency of the human anti-rabies response in vitro, 
human PBL were separated into T cells and non-T cells by 
rosetting of T  cells with neuraminidase-treated SE. The  T  cells 
and non-T cells obtained were cultured with rabies vaccine 
separately or were reconstituted at various T to B ratios. As 
shown in Figure 5, neither  T  cells  nor  non-T  cells  alone  responded 
after  stimulation with rabies  vaccine,  whereas  combined  T cells 
and  non-T cells responded  almost  as  well  as  unseparated PBL. 
Maximal anti-rabies antibody formation by 1 x IO6 non-T cells 
was  obtained  by  the  addition of 0.75 x 1 O6 to 1.25 x 1 O6 T  cells. 
These results indicate that the anti-rabies response is T cell 
dependent. When more than 30% monocytes were present in 
cultures,  specific  antibody  production  decreased.  To  standardize 
the  system,  monocytes  were  always  removed  by  adherence to 
plastic, and the percentage of monocytes in cultures was ad- 
justed to 5 to 10% (data  not  shown). 
DISCUSSION 
Thus  far  studies  on  the host immune  response to viruses  have 
been  performed  largely in experimental  animals. In the  present 
paper,  we  have  described  a  simple  and  reproducible culture and 
assay  system for the  specific  stimulation  of  unselected  human 
PBL with rabies  virus  and  for  the  subsequent  detection  of  rabies 
virus-specific  antibodies  in  culture  supernatant  fluids  by ELISA. 
Some  investigators  have  recently reported  the  successful  acti- 
vation  of  human B lymphocytes in vitro  with  influenza  virus (1 6, 
17) and  varicella  zoster  virus (1 8) as  well  as  the  measurement  of 
virus-specific  antibodies in culture  supernatant  fluids. 
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In these  systems,  however,  as  well  as in most  other  human 
models  described  thus  far,  PBL  were  taken  from  individuals  who 
had  been  previously  primed for  the  antigens  that  have  been  used 
to trigger  antibody  responses in vitro judged  by  serum  antibody 
(14, 15, 24, 26). As  a  consequence it is  reasonable to assume 
that reexposure to these antigens may occur at any moment 
during  a  lifetime.  Because the  kinetics of the  circulating  B  cell 
repertoire is greatly influenced upon contact of the immune 
system with these recall antigens (24, 27-29), those systems 
may not be  the most  ideal  tools to study B cell  activation  in  man. 
In the present study a vaccine against rabies virus has been 
used to trigger  an in vitro immune  response of PBL  from  subjects 
after in vivo primary  sensitization  with  the  same  vaccine.  Rabies 
is usually  always  fatal  unless  immediate  local  wound  treatment 
is done  and  postexposure  prophylaxis  is  administered. Conse 
quently  this  virus,  apart  from  being  of  biologic  importance,  must 
be  considered to be  a  new  antigen  for  most  individuals.  Indeed, 
rabies  virus  serum  antibodies  have not been  demonstrated  thus 
far in individuals  who  have not experienced  vaccination  or  infec- 
tion and  postexposure  treatment. 
This  study  clearly  demonstrates  that in vitro synthesis  of  rabies 
virus-specific  IgM  antibody  triggered  by  DKCV in vitro requires 
primary immunization. The rabies virus-specific IgM antibody 
response  induced  by  DKCV in vitro seems to follow  the  same 
pattern of  responsiveness  as  has  been  found for anti-KLH IgM 
antibody response of PBL of immunized subjects induced by 
KLH in vitro (11). In  contrast,  however, to the  results  reported 
by Lane et al. (II) ,  unresponsiveness to antigen after a 4-wk 
booster  immunization  was  not  observed  in  the  course f a  rabies 
virus-specific  IgM  antibody  response.  When  followed  over  time, 
rabies  virus-specific  IgM  antibody  was  produced in vitro by  PBL 
of  most  individuals  at  a  rather  constant  quantity  until  at  least 12
wk  after  the first  booster  immunization. 
The temporary appearance in the circulation of cells that 
secrete  rabies  virus-specific  antibody  without in vitro exposure 
to DKCV  may  reflect  the  presence  of in  vivo primed  rabies  virus- 
reactive cells that in vitro can  be  induced  easily  by  nonspecific 
factors  generated  in  the  culture  system to differentiate to anti- 
body-secreting cells (30). Another possibility may be that this 
transient  phenomenon  represents  the  appearance in  the  circu- 
lation  of  a  subset  of  antigen-reactive  B  cells  that  spontaneously 
synthesize  specific  IgM  antibody  without  the  need  for  an  addi- 
tional signal in vitro. From the kinetics of appearance in the 
circulation, as well as the differential requirements for an anti- 
genic  stimulus in vitro to differentiate to antibody-secreting  cells, 
it cannot be deduced at present whether spontaneously IgM- 
secreting cells and in vitro DKCV-induced IgM-producing cells 
represent  different  maturational  stages  of  the  same  B  cell  subset 
or  if  they  developed  independently.  With  regard to the  decline of 
the in vitro DKCV-triggered specific IgM response between 6 
and  13  wk  after  primary  immunization,  the  depletion  of  circulating 
long-term  memory  cells  soon after in  vivo immunization  has  been 
reported in rat and mouse (31, 32). The assumption that anti- 
rabies  virus  IgM-producing  cells  represent  long-term  memory B 
cells is  supported  by  the  observation  that  specific  IgG  production 
becomes detectable after the first booster immunization and 
continuously  increases  after  repeat  booster  immunization  3  wk 
later.  Saxon et a/. (28) and  Stevens et  a/. (27), however, reported 
data to suggest  that  long-term  memory  cells  may  be  processed 
by lymph nodes to become short-term memory cells that are 
large lymphoblastoid B cells spontaneously secreting specific 
IgG. 
In the present study, spontaneous rabies virus-specific IgG 
production has not been observed. Short-term memory cells 
have  been  shown to be  only  demonstrable in  circulation  between 
days 5 and 12 after  booster  immunization (27). The  time  intervals 
for  collecting  blood  samples  in  our  study  were 2 or  3  wk. As a 
consequence,  the  phenomenon  of  spontaneous  IgG  production 
by short-term memory cells may not have  been  detected  in  the 
present  study. 
The  antibody  response  observed  here  requires  T  cell  help,  as 
well as the presence of antigen in the induction phase. This 
observation  is  compatible  with  results  obtained  in  similar  systems 
in  which  influenza  virus  and  varicella  zoster  virus  were  used  as 
inducing antigens (16-18). There was a diminution in the re- 
sponse to rabies  virus  at  high  antigen  concentrations  in  culture. 
Although  the  induction  or  activation  of  suppressor  T  cells  could 
be  an  explanation  for  this  phenomenon,  the  tolerization  of  B cells 
by  antigen  cannot  be  excluded (1 1, 33-36).  The  T  cell  depend- 
ency  of  the  anti-rabies  antibody  response  has  also  been  docu- 
mented  in  experimental  animals  by  using  nude  mice  and  cyclo- 
phosphamide-treated  animals  and  by  adoptive  transfer  studies 
(37-40).  The  role  of  T  cells  in  the  regulation  of  the  human  anti- 
rabies  response in vitro is  currently  under  study. 
A number of explanations may be suggested regarding the 
finding that  in  culture  supernatant  fluids  of  PBL  of  some  individ- 
uals,  apparently  only  nonneutralizing  anti-rabies  virus  antibodies 
were  detected. 
First,  the ELSA must  be  considered to be  more  sensitive  than 
RFFIT. In 10- to 100-fold concentrated  PBL  culture  supernatant 
fluids  of  those  individuals,  however,  neutralizing  antibodies  could 
not be  found. 
Another  explanation  for  the  lack  of  neutralizing  antibodies  in 
culture supernatant fluids of PBL of some individuals may be 
that  B cells responsible for  the  production  of  neutralizing  anti- 
bodies  were  not  present  in  the  circulation  or  had  become  unre- 
sponsive to antigen  exposure in vitro. The  presence  of  neutral- 
izing  antibodies in sera  of  the  subjects in  question  need  not  be 
in  contradiction  with  this  explanation. 
Kinetics  studies  on  the  appearance  of  circulating  memory  B 
cells for the different proteins of rabies virus combined with 
precursor frequency analysis of the respective subsets are in 
progress.  Furthermore,  the  use  of PBA, as  well  as  subunits of 
rabies  virus (41 -45), for in vitro stimulation  of  lymphoid  cells  from 
different organ  sources  may  help to clarify  this  intriguing  obser- 
vation. 
The  stimulation  of  human  PBL with  this biologically  relevant 
antigen  that is also  applicable in  vivo is  potentially  a  valuable tool 
for the  dissection  of  the  function  of  human  T,  as  well  as  B  cells, 
in the  antibody  response to rabies  virus. In  addition,  this  tech- 
nique, using a simple and highly reproducible method for the 
detection  of  specific  antibody,  may  prove to be  a  Useful  system 
for potency  testing  of  vaccines in vitro. 
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